Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial

By afschroeder • February 11, 2026

Bishop CW, Ashfaq A, Choe J, Strugnell SA, Johnson LL, Norris KC, Sprague SM. Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial. Am J Nephrol. 2026;57(1):109-119. doi: 10.1159/000546615. Epub 2025 Jun 4. PMID: 40466630; PMCID: PMC12193742.

Tags: end-stage kidney disease, Extended-release calcifediol, General Internal Medicine, Hemodialysis, Parathyroid hormone, Publications, secondary hyperparathyroidism

Assessing the Reliability of Telehealth Geriatric Screening in Older Adults Undergoing Surgery

Canales C, Ivanson HC, Brooks R, Smith J, Boulos NM, Grogan T, Singh S, Sarkisian C, Cannesson M, Whittington R. Assessing the Reliability of Telehealth[...]

Early discontinuation of chemotherapy in older adults with early breast cancer: results from the prospective multicenter HOPE study

Ji J, Sun CL, Dale W, Cohen HJ, Kim H, Katheria V, Baclig N, Zektser Y, Niknafs A, Margolis S, Lee C, Smith C, Sedrak[...]

Federal Housing Assistance, Treatment, and Survival in Older Adults With Non-Small Cell Lung Cancer

Fan Q, Hu X, Warren JL, Soulos PR, Katana Ogongo M, Blackford AL, Craig TK, Hussaini SMQ, Chen KL, Feliciano J, Gross CP, Polsky D,[...]